Facts and reflections on COVID-19 and anti-hypertensives drugs.

Facts and reflections on COVID-19 and anti-hypertensives drugs. Drug Discov Ther. 2020 Mar 26;: Authors: Marin GH Abstract Based on some publications that associate SARS-CoV-2 infection with the use of anti-hypertensive drug groups such as angiotensin-converting-enzyme inhibitors (e.g. enalapril) or angiotensin II receptor blockers (e.g. losartan), many patients from South America, Central America or Spain, have stopped or intend to interrupt their treatments with these drugs. Hence, it may exist ominous consequences due to this drop out. For this reason, it is necessary to quickly warn about this situation and the risks associated with it. PMID: 32213760 [PubMed - as supplied by publisher]
Source: Drug Discoveries and Therapeutics - Category: Drugs & Pharmacology Tags: Drug Discov Ther Source Type: research

Related Links:

Publication date: Available online 4 June 2020Source: Obesity Research &Clinical PracticeAuthor(s): Diego Moriconi, Stefano Masi, Eleni Rebelos, Agostino Virdis, Maria Laura Manca, Salvatore De Marco, Stefano Taddei, Monica Nannipieri
Source: Obesity Research and Clinical Practice - Category: Eating Disorders & Weight Management Source Type: research
Authors: Talevi D, Socci V, Carai M, Carnaghi G, Faleri S, Trebbi E, di Bernardo A, Capelli F, Pacitti F Abstract The coronavirus disease 2019 (CoViD-19) caused by the novel Coronavirus strain SARS-CoV-2 is currently a pandemic. On January 30, 2020, the World Health Organization declared that the CoViD-19 outbreak is a public health emergency of international concern. The virus has already had a direct impact on the physical health of million people, and besides, it is supposed to pose a mental health threat of great magnitude globally. This review aims at synthesizing mounting evidence concerning the immediate psy...
Source: Rivista di Psichiatria - Category: Psychiatry Tags: Riv Psichiatr Source Type: research
by Gertrud U. Rey Does a first infection with SARS-CoV-2 make a person immune to a second infection? This question is one of the prevailing issues in the current pandemic.  The relevant immune response is adaptive immunity, which initiates during a first exposure to a pathogen and protects from re-infection and disease upon a second […]
Source: virology blog - Category: Virology Authors: Tags: Gertrud Rey COVID-19 immunity neutralizing antibody pandemic SARS-CoV-2 T cells vaccine viral virology virus viruses Source Type: blogs
This article discusses the value of studying past social and psychological responses to pandemics and natural disasters in understanding reactions to coronavirus disease of 2019 (COVID-19). By examining severe acute respiratory syndrome (SARS) experiences ...
Source: SafetyLit - Category: International Medicine & Public Health Tags: Economics of Injury and Safety, PTSD, Injury Outcomes Source Type: news
The novel coronavirus (SARS-CoV-2) and the associated disease it causes, COVID-19, have caused unprecedented social disruption. Due to sweeping stay-at-home orders across the United States and internationally, many victims and survivors of domestic violenc...
Source: SafetyLit - Category: International Medicine & Public Health Tags: Home and Consumer Product Safety Source Type: news
Conditions:   COVID;   SARS-CoV 2 Intervention:   Other: SARS-CoV2 Infection Sponsor:   St George's University Hospitals NHS Foundation Trust Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
Condition:   SARS-CoV-2 Infection (COVID-19) Interventions:   Drug: Colchicine plus symptomatic treatment (paracetamol);   Drug: Symptomatic treatment (paracetamol or best symptomatic treatment based on doctor recommendations) Sponsors:   Instituto de Investigación Marqués de Valdecilla;   Gerencia de atención primaria área 1;   Gerencia de atención primaria área 2;   Gerencia Atencion Primaria Area 3;   Gerencia de atenció...
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
Conditions:   Covid-19;   Pulmonary Fibrosis Interventions:   Diagnostic Test: Pulmonary function tests;   Diagnostic Test: Imaging;   Biological: Blood sampling Sponsor:   Medical University Innsbruck Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
Condition:   COVID19 Interventions:   Diagnostic Test: RT-PCR SARS-Cov2;   Diagnostic Test: Sars-Cov2 serology Sponsors:   Centre Hospitalier Intercommunal Creteil;   ACTIV;   GPIP;   GFRUP Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
Conditions:   Coronavirus Infection;   Pregnancy Complications;   Vertical Transmission of Infectious Disease;   Breastfeeding;   Neonatal Infection Intervention:   Diagnostic Test: RT PCR SARS-CoV-2 Sponsor:   Universidade Nova de Lisboa Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: COVID-19 | Cozaar | Drugs & Pharmacology | Enalapril | Losartan | SARS | Spain Health